✦ LIBER ✦

Related drugs for follow-up treatment a case of Crohn's disease

✍ Scribed by A. Wegener

Book ID: 117061590
Publisher: Harcourt Health Sciences
Year: 1993
Tongue: English
Weight: 186 KB
Volume: 82
Category: Article
ISSN: 0007-0785
DOI: 10.1016/s0007-0785(05)80963-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CROHN'S DISEASE : A FOLLOW-UP OF TWO PAT

CROHN'S DISEASE : A FOLLOW-UP OF TWO PATIENTS

✍ Harmer, Michael; Bailey, Joe 📂 Article 📅 1975 🏛 The Lancet 🌐 English ⚖ 170 KB

Long-term follow-up of strictureplasty f

Long-term follow-up of strictureplasty for Crohn's disease

✍ N. S. Fearnhead; R. Chowdhury; B. Box; B. D. George; D. P. Jewell; N. J. McC. Mo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Adalimumab for recurrent orbital myositi

Adalimumab for recurrent orbital myositis in Crohn's disease: Report of a case with a 3-year follow-up

✍ María-Luisa Hernández-Garfella; Alicia Gracia-García; Enrique Cervera-Taulet; Ca 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 292 KB

Natural history of perianal Crohn's dise

Natural history of perianal Crohn's disease: Ten year follow-up: A plea for conservatism

✍ Peter Buchmann; Michael R.B. Keighley; Robert N. Allan; Henry Thompson; John Ale 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 308 KB

A rare case of pericarditis, complicatio

A rare case of pericarditis, complication of infliximab treatment for Crohn's disease

✍ Joe Devasahayam; Unnikrishnan Pillai; Alexandre Lacasse 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 654 KB

Lewis and Sumner syndrome following infl

Lewis and Sumner syndrome following infliximab treatment in Crohn's disease: A report of 2 cases

✍ Stephane Nancey; Françoise Bouhour; Gilles Boschetti; Christophe Magnier; Pierre 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

To the Editor: Neurological and demyelinating events have been reported rarely in association with the use of tumor necrosis factor a (TNF-a) antagonists, since only 29 cases were reported in patients exposed to infliximab (IFX) worldwide. These demyelinating diseases included multiple sclerosis, o